Japan, June 10 -- SEATTLE CHILDRENS HOSPITAL DBA SEATTLE CHILDRENS RESEARCH INSTITUTE has got intellectual property rights for 'METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T CELLS IN WHICH EXPRESSION OF ENDOGENOUS FOXP3 GENE IS STABILIZED BY GENE RECOMBINATION.' Other related details are as follows:

Application Number: JP,2024-079059

Category (FI): A61P25/00,A61P37/02,A61K35/17,A61K35/28,C12N15/09,110,C12N15/12,C12N15/85@Z,C12N15/09,100,C12N5/10,C12N5/0783,A61P37/06,A61P19/02,A61P29/00,101,A61P1/04

Stage: Grant (IP right granted following substantive examination.)

Filing Date: May 15, 2024

Publication Date: Aug. 6, 2024

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Disclaimer: Curated by HT Synd...